Opicapone Pharmacokinetics and Effects on Catechol- O -Methyltransferase Activity and Levodopa Pharmacokinetics in Patients With Parkinson Disease Receiving Carbidopa/Levodopa.

LeWitt, Peter; Liang, Grace S; Olanow, C Warren; Kieburtz, Karl D; Jimenez, Roland; Olson, Kurt; Klepitskaya, Olga; Loewen, Gordon

LeWitt, Peter; Liang, Grace S; Olanow, C Warren; Kieburtz, Karl D; Jimenez, Roland; Olson, Kurt; Klepitskaya, Olga; Loewen, Gordon.

Afiliação

LeWitt P; Department of Neurology, Wayne State University School of Medicine and Henry Ford Hospital, Detroit, MI.
Liang GS; Neurocrine Biosciences, Inc, San Diego, CA.
Kieburtz KD; Clintrex Research Corporation, Sarasota, FL.
Jimenez R; Neurocrine Biosciences, Inc, San Diego, CA.
Olson K; Neurocrine Biosciences, Inc, San Diego, CA.
Klepitskaya O; Neurocrine Biosciences, Inc, San Diego, CA.
Loewen G; Neurocrine Biosciences, Inc, San Diego, CA.

Clin Neuropharmacol ; 46(2): 43-50, 2023.

Article em En | MEDLINE | ID: mdl-36688497

Assuntos

Levodopa; Doença de Parkinson; Humanos; Levodopa/uso terapêutico; Levodopa/farmacocinética; Carbidopa; Doença de Parkinson/tratamento farmacológico; Antiparkinsonianos/farmacocinética; Inibidores de Catecol O-Metiltransferase/farmacologia; Catecol O-Metiltransferase

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Levodopa Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans Idioma: En Revista: Clin Neuropharmacol Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google